Cour Pharmaceuticals Development Funding: $135M Raised
Cour Pharmaceuticals Development is based in Chicago. It has raised $135M in total funding. Latest round: Series A.
Cour Pharmaceuticals Development funding overview
Cour Pharmaceuticals Development is based in Chicago. Cour Pharmaceuticals Development has raised $135M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Cour Pharmaceuticals Development runs through 2024; nothing later has been disclosed. Investors on record include Lumira Ventures, Alpha Wave Ventures, Roche Venture Fund, Pfizer, Bristol Myers Squibb. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Cour Pharmaceuticals Development funding
How much has Cour Pharmaceuticals Development raised?
Cour Pharmaceuticals Development has raised $135M in total disclosed funding across the rounds on record.
Who has invested in Cour Pharmaceuticals Development?
Lumira Ventures, Alpha Wave Ventures, Roche Venture Fund, Pfizer, Bristol Myers Squibb are named among the investors backing Cour Pharmaceuticals Development.
What was the latest Cour Pharmaceuticals Development funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Cour Pharmaceuticals Development based?
Cour Pharmaceuticals Development is based in Chicago.
When did Cour Pharmaceuticals Development last raise?
The last disclosed Cour Pharmaceuticals Development round closed in January 2024 at Series A.
We update the Cour Pharmaceuticals Development record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Chicago and their backers are listed below.
Companies related to Cour Pharmaceuticals Development (36)
